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Abstract
Kashin-Beck Disease (KBD) is an endemic osteochondropathy, the pathogenesis of which remains unclear now. In this study,
we compared gene expression profiles of articular cartilage derived respectively from KBD patients and normal controls.
Total RNA were isolated, amplified, labeled and hybridized to Agilent human 1A 22 k whole genome microarray chip. qRT-
PCR was conducted to validate our microarray data. We detected 57 up-regulated genes (ratios $2.0) and 24 down-
regulated genes (ratios #0.5) in KBD cartilage. To further identify the key genes involved in the pathogenesis of KBD,
Bayesian analysis of variance for microarrays(BAM) software was applied and identified 12 potential key genes with an
average ratio 6.64, involved in apoptosis, metabolism, cytokine & growth factor and cytoskeleton & cell movement. Gene
Set Enrichment Analysis (GSEA) software was used to identify differently expressed gene ontology categories and pathways.
GSEA found that a set of apoptosis, hypoxia and mitochondrial function related gene ontology categories and pathways
were significantly up-regulated in KBD compared to normal controls. Based on the results of this study, we suggest that
chronic hypoxia-induced mitochondrial damage and apoptosis might play an important role in the pathogenesis of KBD.
Our efforts may help to understand the pathogenesis of KBD as well as other osteoarthrosis with similar articular cartilage
lesions.
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Introduction
Kashin-Beck Disease (KBD) is an endemic osteochondropathy
characterized by chondrocyte necrosis and apoptosis, cartilage
degeneration and matrix degradation[1]. KBD usually occurs in
children aged 3–12 years with patients exhibiting short stature,
joint deformities, and other features caused by impaired epiphyseal
growth and ossification[1,2]. With age, secondary osteoarthritis
and deformities of multiple joints become evident in KBD
patients[1,3]. Currently, KBD is mainly prevalent at specific areas
of China, Siberia, and North Korea[2,3]. For instance, more than
2.5 million people suffer from KBD, and about 30 million people
are at the risk of KBD in China[4]. Because of osteoarthritis and
joint deformities, most of KBD patients without effective
treatments will partly or completely lost their abilities to work
and even self-care, which not only significantly reduces their
quality of life, but also brings heavy medical and financial burdens
to society.
Because the pathogenesis of KBD remains unclear, there is not
effective approach for preventing and curing KBD now. Most of
current treatments of KBD focus on releasing the pain caused by
secondary osteoarthritis and joint deformities of KBD[5].
Understanding the pathogenesis of KBD is the key to develop
effective measures for preventing and curing KBD. Through
epidemiological studies, researchers proposed various environ-
mental etiologic hypotheses for KBD, such as selenium deficiency
and cereal contamination by mycotoxins[3,6,7,8,9]. However, the
roles of these environmental risk factors in the pathogenesis of
KBD remain under debate now, and none of these environmental
etiologic hypotheses can completely explain the pathological
changes of KBD. Additionally, recent studies reported that
susceptibility genes might contribute to the pathogenesis of
KBD[10,11]. Current epidemiological and genetic study results
suggest that KBD was a complex disease, the risk of which was
determined by multiple environmental and genetic risk fac-
tors[12].
With the rapid development of high-throughput microarray
technology, comparing genome-wide gene expression profiles
between case and control groups becomes possible now.
Significantly differentially expressed genes are likely to involve in
the development of target diseases, and may provide insight for
pathogenetic studies. Current gene expression analysis can be
generally classified into two classes: single gene expression analysis
and gene set expression analysis. Single gene expression analysis
evaluates the expression level of each individual gene without
considering functional relationships among genes. Single gene
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contributing to the pathogenesis of target diseases. However, since
individual gene may have various biological functions, and involve
in multiple cellular processes, knowing which gene involved in the
development of target diseases is usually inadequate for under-
standing the pathogenesis of target diseases. To address this issue,
gene set expression analysis was proposed[13,14], and is wildly
used in current gene expression studies[15,16,17]. Gene set
expression analysis attempts to identify differentially expressed
gene sets that usually belong to the same gene ontology categories
or pathways[13,14]. Because of combining the information of
expression levels and biological functions of multiple genes, gene
set expression analysis is believed to be more powerful than
traditional single gene expression analysis[13].
To identify the genes, gene ontology categories and pathways
involved in the pathogenesis of KBD, we compared genome-wide
gene expression profiles of articular cartilage derived respectively
from KBD patients and normal controls in this study. Both single
gene expression analysis and gene set expression analysis were
conducted to ensure the accuracy of our study results, and provide
more functional information of differentially expressed genes in
KBD vs. control. To the best of our knowledge, this study is the
first genome-wide gene set expression analysis of KBD. Our study
results may help to unravel the molecular mechanism underlying
KBD as well as other osteoarthrosis with similar articular cartilage
lesions.
Results
Microarray Data Analysis
Single Gene Expression Analysis. We detected 57 up-
regulated genes (ratios $2.0) and 24 down-regulated genes (ratios
#0.5) in KBD cartilage (detailed in Appendix S1). To further identify
the key genes involved in the pathogenesis of KBD, BAM software
was applied and identified 12 potential key genes with an average
expression ratio 6.64. The 12 genes belong to various functional
categories, mainly including apoptosis related BAX (ratio=3.79),
PERP (ratio=5.59) and TNFRSF11B (ratio=8.53), metabolism
related GALNT1 (ratio=8.16) and IDH2(ratio=4.31), and cytokine
& growth factor related TGFBI (ratio=7.86), IGFBP2 (ratio=9.70)
and IGFBP4 (ratio=4.13) (Table 1).
Gene Set Expression Analysis. Gene ontology expression
analysis results are presented in Table 2. Compared with normal
controls, we identified 23 up-regulated gene ontology categories as
well as 1 down-regulate gene ontology category in KBD. The
identified 24 gene ontology categories are grouped based on their
biological functions. As shown by Table 2, 9 of 23 up-regulated
gene ontology categories involve in the process of apoptosis. The
biological functions of the remaining 14 up-regulated gene
ontology categories mainly include mitochondrial function (4
gene ontology categories), skeleton development (1 gene ontology
category) and extracellular environment (3 gene ontology
categories).
Pathway expression analysis identified 149 up-regulated path-
ways and 20 down-regulated pathways in KBD (detailed in
Appendix S2). Based on the biological functions of the differently
expressed pathways and previous pathogenetic study results of
KBD, 14 important pathways that may contribute to the
pathogenesis of KBD are summarized in Table 3. Consistent with
our gene ontology expression analysis results, 6 apoptosis-related
pathways were significantly up-regulated in KBD, including
REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS,
FRIDMAN_SENESCENCE_UP, REACTOME_APOPTOSIS,
FRIDMAN_IMMORTALIZATION_DN, ALCALA_APOPTO-
SIS and BIOCARTA_CERAMIDE_PATHWAY. We also found
that BIOCARTA_AT1R_PATHWAY that involved in the activa-
tion of apoptosis-related JNK pathway[18], appeared to signifi-
cantly up-regulate in KBD. Another important finding of our
pathway expression analysisisthat 5 hypoxia-relatedpathwayswere
significantly up-regulated in KBD, including HARRIS_HY-
Table 1. Differently expressed genes identified by BAM.
Gene Symbol Gene Title ID Ratio
a P-value
Apoptosis
TNFRSF11B Tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) NM_002546 8.536 8.01 0.0020
PERP PERP, TP53 apoptosis effector NM_022121 5.5962.38 0.0130
BAX BCL2-associated X protein NM_138764 3.7961.53 0.0546
Metabolism
GALNT1 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-
acetylgalactosaminyltransferase 1 (GalNAc-T1)
XM_031104 8.1662.62 0.0024
IDH2 Isocitrate dehydrogenase 2 (NADP+), mitochondrial NM_002168 4.3160.71 0.0351
Cytokine & growth factor
IGFBP2 Insulin-like growth factor binding protein 2, 36 kDa NM_000597 9.7063.73 0.0010
TGFBI Transforming growth factor, beta-induced, 68 kDa NM_000358 7.8663.44 0.0029
IGFBP4 Insulin-like growth factor binding protein 4 NM_001552 4.1361.53 0.0407
Cytoskeleton & cell movement
TMSL8 Thymosin-like 8 NM_021992 9.6568.50 0.0011
ACTG1 Actin, gamma 1 NM_001614 6.85610.68 0.0055
Miscellaneous
GREM1 Gremlin 1, cysteine knot superfamily, homolog (Xenopus laevis) NM_013372 6.7964.81 0.0057
DSCR1 Down syndrome critical region gene 1 NM_004414 4.2763.50 0.0362
aexpression ratio is presented as mean6 standard error of mean.
doi:10.1371/journal.pone.0022983.t001
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IA_METAGENE, ELVIDGE_HYPOXIA_BY_DMOG_UP and
LEONARD_HYPOXIA. Additionally, KEGG_PEROXISOME
playing an important role in the detoxification of reactive oxygen
species (ROS), was significantly up-regulated in KBD.
qRT-PCR Validation of Microarray data
4 up-regulated (ratios .2.0) and 4 down-regulated genes (ratios
,0.5) were selected for quantitative real-time reverse transcription
polymerase chain reaction (qRT-PCR) to validate our microarray
data. qRT-PCR results are presented in Figure 1. We observed
increasing expression levels of CASP8AP2, PAPSS2, TMSL8 and
VEGF in KBD compared to normal controls (ratios .2.0). The
expression levels of BMF, CBR3, POSTN and TACC1 appeared
to decrease in KBD than in normal controls (ratios ,0.5). Gene
expression patterns of the 8 genes in qRT-PCR are consistent with
that in microarray experiment, confirming the validity of our
microarray data.
Discussion
With high-throughput microarray technology, we compared
gene expression profiles of cartilage derived from KBD patients
and normal controls, respectively. Our study results suggest that
chronic hypoxia-induced mitochondrial damage and apoptosis
might play an important role in the pathogenesis of KBD. In the
following, we present some of the identified differently expressed
genes and gene sets, which may contribute to the pathogenesis of
KBD.
Apoptosis
We found that apoptosis-related genes and gene sets were up-
regulated in KBD. Among the 12 potential key genes, 3 genes
involve in the process of apoptosis, including BAX, PERP and
TNFRSF11B. TNFRSF11B[19] and BAX[20] have been report-
ed to be associated with osteoarthrosis by previous studies.
Additionally, 9 apoptosis-related gene ontology categories and 6
apoptosis-related pathways were significantly up-regulated in KBD
compared to normal controls, which supports the importance of
apoptosis in the pathogenesis of KBD. Our results are consistent
with the fact that abnormal chondrocyte apoptosis is one of the
primary pathological changes of KBD[1,21]. However, the
molecular mechanism underlying abnormal chondrocyte apopto-
sis in KBD remains elusive.
Hypoxia
An important finding of this study is that 5 hypoxia-related
pathways were significantly up-regulated in KBD, suggesting that
hypoxia might contribute to the pathogenesis of KBD. This result
is consistent with that of previous studies, which found that
Table 2. Differently expressed gene ontology categories in KBD vs. control.
Gene Ontology Category Function NES
a P-value
Up-regulated
APOPTOTIC_PROGRAM Apoptosis 0.63 ,10
23
INDUCTION_OF_APOPTOSIS_BY_EXTRACELLULAR_SIGNALS Apoptosis 0.63 ,10
23
ANTI_APOPTOSIS Apoptosis 0.44 ,10
23
PROGRAMMED_CELL_DEATH Apoptosis 0.35 0.03
APOPTOSIS_GO Apoptosis 0.35 0.03
NEGATIVE_REGULATION_OF_APOPTOSIS Apoptosis 0.41 0.03
NEGATIVE_REGULATION_OF_PROGRAMMED_CELL_DEATH Apoptosis 0.41 0.03
REGULATION_OF_APOPTOSIS Apoptosis 0.35 0.05
REGULATION_OF_PROGRAMMED_CELL_DEATH Apoptosis 0.35 0.05
SKELETAL_DEVELOPMENT Skeleton development 0.53 0.04
MITOCHONDRIAL_ENVELOPE Mitochondrion related 0.53 0.03
OXIDOREDUCTASE_ACTIVITY_GO_0016616 Oxidation-reduction reaction related 0.34 0.05
OXIDOREDUCTASE_ACTIVITY__ACTING_ON_CH_OH_GROUP_OF_DONORS Oxidation-reduction reaction related 0.34 0.05
CELLULAR_RESPIRATION Aerobic and anaerobic respiration related 0.56 0.03
EXTRACELLULAR_REGION_PART Extracellular environment 0.39 ,10
23
EXTRACELLULAR_REGION Extracellular environment 0.38 ,10
23
EXTRACELLULAR_SPACE Extracellular environment 0.35 0.05
PORE_COMPLEX Membrane passage 0.48 0.03
POSITIVE_REGULATION_OF_HYDROLASE_ACTIVITY Hydrolysis related 0.47 0.05
PHOSPHORIC_DIESTER_HYDROLASE_ACTIVITY Phosphodiester hydrolysis related 0.54 0.03
PROTEIN_OLIGOMERIZATION Protein polymer production 0.57 ,10
23
COFACTOR_METABOLIC_PROCESS Cofactor related 0.52 0.04
ANGIOGENESIS VEGFA related 0.45 0.03
Down-regulated
HYDROLASE_ACTIVITY__HYDROLYZING_O_GLYCOSYL_COMPOUNDS O-glycosyl hydrolysis 20.60 ,10
23
adenotes the normalized enrichment score calculated by GSEA.
doi:10.1371/journal.pone.0022983.t002
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osteoarthritis and rheumatoid arthritis[22,23,24]. The molecular
mechanism of hypoxia-induced articular lesions may partly be
explained by increased production of ROS under hypoxia[25,26],
which are able to promote lipid peroxidation, protein oxidation,
and induce mitochondrial damage and apoptosis[27,28]. In vivo,
ROS are mainly detoxified at peroxisome through special
enzymes, such as glutathione peroxidases, superoxide dismutases
and catalases. In this study, KEGG_PEROXISOME pathway
playing a key role in the detoxification of ROS, was significantly
up-regulated in KBD, which suggested the increased activity of
ROS metabolism in KBD patients compared to normal controls.
Mitochondria related
It is well documented that mitochondria play a critical role in
apoptosis[29]. Several mitochondria-related proteins that can
activate intrinsic apoptotic programs, have been identified, such as
Bcl-2 and BAX [30]. In this study, we found that BAX was up-
regulated in KBD, which was also observed by previous study of
KBD[20]. BAX is one of the proapoptotic members of apoptosis
Figure 1. Histogram showing the expression values of the selected 8 genes measured by microarray and qRT-PCR. * indicates p,0.05
and { indicates p,0.01, calculated by paired t test.
doi:10.1371/journal.pone.0022983.g001
Table 3. Selected pathways significantly up-regulated in KBD vs. control.
Pathway Description NES
a P-value
REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS Genes involved in intrinsic pathway for apoptosis 0.62 ,10
23
FRIDMAN_SENESCENCE_UP Genes up-regulated in senescent cells. 0.54 ,10
23
REACTOME_APOPTOSIS Genes involved in apoptosis 0.42 ,10
23
FRIDMAN_IMMORTALIZATION_DN Genes down-regulated in immortalized cell lines. 0.64 ,10
23
ALCALA_APOPTOSIS Genes able to induce cell death in an expression cDNA library screen. 0.45 ,10
23
BIOCARTA_CERAMIDE_PATHWAY Ceramide signaling pathway 0.67 ,10
23
HARRIS_HYPOXIA Genes known to be induced by hypoxia 0.62 ,10
23
SEMENZA_HIF1_TARGETS Genes that are transcriptionally regulated by HIF1A 0.77 ,10
23
WINTER_HYPOXIA_METAGENE Genes regulated by hypoxia, based on literature searches. 0.51 ,10
23
ELVIDGE_HYPOXIA_BY_DMOG_UP Genes up-regulated in MCF7 cells (breast cancer) treated with
hypoxia mimetic DMOG
0.59 0.027
LEONARD_HYPOXIA Genes up-regulated in HK-2 cells kidney tubular epithelium under
hypoxia and down-regulated on re-oxygenation
0.59 ,10
23
KEGG_PEROXISOME Peroxisome 0.49 ,10
23
GALLUZZI_PERMEABILIZE_MITOCHONDRIA Proteins that permeabilize mitochondria. 0.48 ,10
23
BIOCARTA_AT1R_PATHWAY Angiotensin II mediated activation of JNK pathway via
Pyk2 dependent signaling
0.59 ,10
23
adenotes the normalized enrichment score calculated by GSEA.
doi:10.1371/journal.pone.0022983.t003
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BAX protein laying on the surface of mitochondria, is able to
damage mitochondria and induce apoptosis through permeabiliz-
ing mitochondrial membrane[31,32]. We also found that BAX
involved GALLUZZI_PERMEABILIZE_MITOCHONDRIA
pathway that could permeabilize mitochondria membrane during
mitochondria-mediated apoptosis, was significantly up-regulated
in KBD. Although we observed a marginal significant p value of
0.0546 for BAX in our single gene expression analysis, previous
and our study results suggest that mitochondrial BAX-induced
apoptosis might contribute to the pathogenesis of KBD. Further
studies are needed to investigate the potential effect of BAX on the
risk of KBD.
It has been suggested that hypoxia played an important role in
the pathogenesis of osteoarthrosis, such as osteoarthritis and
rheumatoid arthritis [22,23,24]. However, the potential molecular
mechanism underlying hypoxia-induced articular lesions in
osteoarthrosis remains under debate. Researchers proposed
various hypothesis about the role of hypoxia in the pathogenesis
of osteoarthrosis, such as abnormal energy metabolism and
immune & inflammation[33]. Our previous study observed
abnormal functional changes of mitochondria in the cartilage of
KBD, and suggested that mitochondrial dysfunction might
contribute to the abnormal chondrocyte apoptosis of KBD [34].
Based on our study results, we suggest that hypoxia-induced
mitochondrial damage and apoptosis might play an important role
in the pathogenesis of KBD. Previous study results may provide
some evidence for this etiologic hypothesis. It has been reported
that hypoxia could increase mitochondrial production of
ROS[25,26], which were able to induce apoptosis through
activating mitochondrial JNK pathway[35]. Another study found
that activated JNK pathway could promote the phosphorylation of
BAX protein following by triggering mitochondria-mediated
apoptosis[36]. In this study, we found that BAX gene, 6 apoptosis
related pathways, 5 hypoxia-related pathways, ROS metabolism–
related KEGG_PEROXISOME pathway, and BIOCAR-
TA_AT1R_PATHWAY pathway involved in the activation of
JNK pathway, were simultaneouly up-regulated in KBD, which
supported the role of hypoxia-induced mitochondrial damage and
apoptosis in the pathogenesis of KBD.
Mycotoxins, selenium deficiency and humic substance are
regarded as three important environmental risk factors of
KBD[1,3,6,37,38]. The molecular mechanisms of cartilage lesions
caused by mycotoxins, selenium deficiency and humic substance
remain unclear now. Our study results may provide some evidence
for understanding the roles of mycotoxins, selenium deficiency and
humic substance in the pathogenesis of KBD. Previous studies
have reported that mycotoxins could result in hypoxia[39], and
increase the production of ROS in vivo[40]. In this study, we
observed that hypoxia and ROS metabolism related pathways
were significantly up-regulated in KBD. Based on the biological
effects of mycotoxins and our study results, we may infer that the
causative effects of mycotoxins might partly be attributed to
hypoxia and ROS induced cartilage lesions in KBD. Additionally,
as an important metabolism enzyme of ROS, glutathione
peroxidase is a selenium-containing enzyme, and its protective
effect against ROS largely depends on the presence of seleni-
um[41]. Selenium deficiency may result in the loss of protective
function of glutathione peroxidase against ROS, and therefore
increase susceptibility to KBD[12]. For humic substance, it was
suggested that humic substance could induce oxidative stress
(imbalance between the production and detoxification of ROS),
which might contribute to the cartilage lesions of KBD [42,43,44].
The significant up-regulation of ROS metabolism–related
pathway in KBD observed by our study may provide some
evidence for this etiologic hypothesis.
Two aspects of our study deserve further emphasizing. First,
because KBD usually becomes evident in children coming from
specific areas with similar environment (for example selenium
deficiency), the causative factors of KBD should be less than that
of other osteoarthrosis, such as osteoarthritis and rheumatoid
arthritis, which occur in adults and mostly in elderly persons. The
etiologic heterogeneity of KBD should be smaller than that of
other osteoarthrosis, the risks of which are determined by
cumulative effects of multiple genetic and environmental causative
factors during life span. Therefore, KBD is ideal for molecular
mechanism studies of articular cartilage lesions in osteoarthrosis.
The differently expressed genes and gene sets identified by this
study may provide insight for addressing the pathogenesis of KBD
as well as other osteoarthrosis with similar articular cartilage
lesions. Second, gene set expression analysis is first applied to the
pathogenetic studies of KBD in this study. Because of combining
the functional and expressing information of multiple genes, gene
set expression analysis should be more powerful than traditional
single gene expression analysis. It may help us to identify
important pathways involved in the pathogenesis of KBD, which
are usually difficult to be detected by single gene expression
analysis.
In summary, we compared genome-wide gene expression
profiles of KBD and normal controls, and identified a set of
differently expressed genes, gene ontology categories and path-
ways. Based on the results of this study, we suggest that chronic
hypoxia induced mitochondrial damage and apoptosis might play
an important role in the pathogenesis of KBD. Our efforts may
help to understand the molecular mechanism underlying KBD as
well as other osteoarthrosis with similar articular cartilage lesions.
Materials and Methods
All studies were approved by the Institutional Review Board of
Xi’an Jiaotong University. Informed-consent documents were
written by all KBD patients and the relatives of donors before
entering this study.
Cartilage Sample Collection
Articular cartilage samples were collected from 9 KBD patients
and 9 normal controls, respectively. All study subjects were
Chinese Han. Every year, there are 100 randomly selected
patients with serious KBD undergoing free total knee replacement
surgery, which was supported by Shaanxi province of China. Our
9 KBD patients were randomly selected from the KBD patients
undergoing free total knee replacement surgery, and came from
the KBD prevalent areas-Linyou county and Yongshou county of
Xi’an city of Shaanxi province of China. Based on the radiography
of right hand, knee and hip joints, and cartilage sections after
hematoxylin and eosin (H&E) staining (Figure 2), KBD patients
were diagnosed as having grade II or III KBD according to the
KBD clinical diagnosis criteria of China (Diagnostic code:
GB16395-1996)[45]. The cartilage samples of normal controls
were collected from the knees of fresh cadaver within 8 hours of
death caused by traffic accidents. 9 cadaver donors came from the
non-KBD prevalent counties of Xi’an city, the economic
conditions and living habits of which were similar to that of
Linyou and Yongshou counties. KBD, genetic bone and cartilage
diseases, osteoarthritis and rheumatoid arthritis were excluded for
the 9 cadaver donors by cartilage section examination with H&E
staining. All cartilage samples were derived from the same
anatomic area of femoral condyles of knee. The obtained cartilage
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subsequently stored at 280uC until RNA extraction. Specific for
this study, four and five KBD-control pairs, matched for age and
sex, were used for microarray and qRT-PCR, respectively
(Table 4).
RNA Preparation
Frozen cartilage of each sample was first rapidly ground in
liquid nitrogen using freezer mill (SPEX CertiPrep, Metuchen, NJ,
USA). Total RNA were then isolated from cartilage samples using
the Agilent Total RNA Isolation Mini kit (Agilent Technologies,
Santa Clara, CA, USA) following manufacturer recommended
protocol. The quality and integrity of isolated total RNA were
evaluated with 1% agarose gel electrophoresis.
Microarray Hybridization
Total RNA were first transcribed into cDNA, and labeled with
CyDye using the Amino Allyl MessageAmp aRNA Kit (Applied
Biosystems, Austin, TX, USA). For each KBD-control pair, 0.5 mg
of labeled cDNA were then purified separately and mixed together
with hybridization buffer (Agilent In Situ Hybridization Plus kit).
Agilent Human 1A 22 k Whole Genome microarray (G4110B)
that contains 22,575 oligonucleotides probes representing 21,073
human genes, was applied for microarray hybridization following
Agilent recommended protocol. Hybridization signals were
recorded by Agilent G52565BA scanner, and analyzed by Feature
Extraction 9.3 (Agilent Technologies) and Spotfire 8.0 (Spotfire
Inc., Cambridge, MA, USA) software. The quality of fluorescent
spots was evaluated by Feature Extraction 9.3. The fluorescent
spots that failed to pass the quality control procedure were
excluded from further analysis. Linear and LOWESS normaliza-
tion were conducted to eliminate possible dye-related bias in our
microarray data. The gene expression data obtained from Spotfire
8.0 was imported into Excel spreadsheets (Microsoft Corp.,
Redmond, WA, USA) for downstream data analysis. Our
microarray data was MIAME compliant and has been deposited
in the MIAME compliant database ArrayExpress (Accession
number:E-MEXP-3196).
Microarray Data Analysis
Single Gene Expression Analysis. Gene expression ratios
were calculated from the microarray data. Up-regulated and
down-regulated genes were identified by ratios $2.0 and #0.5,
respectively. To further identify the key genes involved in the
pathogenesis of KBD, Bayesian analysis of variance for
microarrays (BAM, http://www.bamarray.com/) software was
applied to our genome-wide microarray data [46,47]. The
overlapped genes between the gene set identified by BAM and
the gene set with ratios $2.0 or #0.5 were regarded as the
potential key genes of KBD in this study. BAM was running under
developers recommended parameters. Statistical p values were
calculated for each gene using Agilent p value log ratio algorithm
(Agilent Technologies)[1], defined by
P~1{Erf
jxdevj
ﬃﬃﬃ
2
p
  
~Erfc
jxdevj
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2
p
  
;
where Erf was calculated by
Erf x ðÞ ~
2
ﬃﬃﬃﬃ
pi
p
ðx
0
e{t2
dt:
Erf(x) denotes twice the integral of Gaussian distribution with
mean value 0 and variance 0.5; xdev denotes the deviation of log
ratio from 0.
Gene Set Expression Analysis. To investigate the gene
expression patterns of KBD in the context of molecular functions,
biological processes and cellular components, Gene Set
Enrichment Analysis (GSEA, http://www.broadinstitute.org/
gsea/index.jsp) software was used here to evaluate the
Table 4. KBD-control sample pairs used for microarray and
qRT-PCR.
KBD Control
Age(years) Sex Age(years) Sex
Microarray sample set 55 Male 55 Male
52 Male 54 Male
49 Female 48 Female
42 Male 37 Male
qRT-PCR sample set 69 Male 60 Male
57 Female 58 Female
51 Male 58 Male
50 Male 56 Male
44 Female 34 Female
doi:10.1371/journal.pone.0022983.t004
Figure 2. Characteristics of Kashin-Beck disease (KBD). A&B,
images of left hand(A, left male patient aged 55 years) and knees (B, left
female patient aged 44 years, middle male patient aged 42 years, right
female patient aged 49 years) from representative patients with grade II
or III KBD; C, radiographic images of left and right hands of a KBD
patient exhibiting shortened phalanges, enlarged bone ends of
phalanges, and narrowed joint space; D, radiographic images of left
and right knees of a KBD patient exhibiting widened and narrowed joint
space; E–G, hematoxylin and eosin staining of adult articular cartilage
from a healthy subject (E) and two patients with grade II (F) or III (G)
KBD (original magnification6100).
doi:10.1371/journal.pone.0022983.g002
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known biological knowledge, such as gene ontology categories and
biochemical pathways[13,14]. During gene set expression analysis,
GSEA calculated an enrichment score (ES) for each gene set,
which reflected the over-represented degree of corresponding gene
set. The gene sets with extreme ES values were suggested to be
correlated with study phenotypes by GSEA[13,14]. GSEA gene
ontology collection 3.0 and curated gene set collection 3.0 were
downloaded from the Molecular Signature Database (http://
www.broadinstitute.org/gsea/msigdb/index.jsp), and applied to
GSEA for gene ontology and pathway expression analysis,
respectively. GSEA gene ontology collection 3.0 contains 1,454
gene ontology categories. GSEA curated gene set collection 3.0
contains 3,272 molecular pathways. Statistical p values were
calculated by GSEA for each gene set. Significant threshold was
set as p values #0.05 in this study.
qRT-PCR Validation
qRT-PCR was conducted to validate our microarray data using
an independent sample set (Table 4). 4 up-regulated genes (ratios
.2.0) and 4 down-regulated genes (ratios ,0.5) in our microarray
experiment were randomly selected for qRT-PCR, including
BMF, CBR3, CASP8AP2, PAPSS2, POSTN, TACC1, TMSL8
and VEGF. Total RNA were isolated from cartilage samples, and
prepared in the same way as used by the microarray experiment.
The isolated total RNA were converted into cDNA using
Superscript II reverse transcriptase (Invitrogen, Carlsbad, CA,
USA). Amplification and detection of cDNA were performed using
ABI 7500 Real-Time PCR Detection System (Applied Biosystems)
following manufacturer recommended protocol. Glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) was simultaneously assayed
by qRT-PCR as an endogenous invariant control for data
normalization. All primer and probe sets of qRT-PCR were
supplied by TaqMan Gene Expression Assays (Applied Biosys-
tems). The expression values of the 8 genes were normalized to the
amount of GAPDH, and used for calculating expression ratios.
Paired t test was conducted to assess the significance levels of
expression differences of the 8 genes between KBD patients and
normal controls.
Supporting Information
Appendix S1 Single gene expression analysis results in KBD vs.
control.
(XLS)
Appendix S2 Pathway expression analysis results in KBD vs.
control.
(XLS)
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